Key result
High-dose verapamil and diltiazem reduced angina attacks and increased treadmill time in patients with stable exertional angina.
Why the study?
Do high-dose verapamil and diltiazem reduce angina attacks and improve exercise capacity in patients with stable exertional angina?
RCT (n=46)
Double-blind
Do high-dose verapamil and diltiazem reduce angina attacks and improve exercise capacity in patients with stable exertional angina?
High-dose verapamil and diltiazem are both safe and effective for the long-term reduction of angina attacks and improvement of exercise capacity in patients with stable exertional angina.
Answers are grounded in this paper and cite their sources.
Supports high-dose verapamil or diltiazem for stable angina; confirms RCT efficacy for symptom control and exercise capacity.
The efficacy and safety of high-dose verapamil (480 mg/day) and diltiazem therapy (360 mg/day) were compared in separate cohorts of 26 and 20 patients, respectively. All patients had stable exertional angina and underwent an initial 6-week double-blind, placebo-controlled, randomized phase followed by a 12-month open-label period. Angina attacks were reduced by verapamil (6.3 +/- 7.5 to 2.5 +/- 4.1 attacks per week, p less than 0.001) and by diltiazem (9.2 +/- 7.5 to 3.0 +/- 3.1 attacks per week, p less than 0.001), while treadmill time increased with both verapamil (372 +/- 132 to 444 +/- 108 s, p less than 0.001) and diltiazem (412 +/- 175 to 536 +/- 164 s, p less than 0.001) during the short-term study. Both agents continued to show similar salutory effects at the end of one year. The beneficial effects of both drugs appeared to be related in part to a reduction of the rate-pressure product during submaximal exercise (12% by verapamil, 7% by diltiazem, both p less than 0.05). Adverse effects were few and consisted primarily of mild constipation in six patients taking verapamil, and pedal edema and transient flushing in 2 patients each using diltiazem. Thus, high-dose verapamil and diltiazem have similar beneficial effects and are safe for the long-term treatment of effort-related angina pectoris.
No takes yet. Share an insight, caveat, or question.
Weiner et al. (1984) conducted an RCT in Stable exertional angina (n=46). Verapamil and diltiazem vs. Placebo was evaluated on Angina attacks per week and treadmill time (p=<0.001). High-dose verapamil and diltiazem reduced angina attacks and increased treadmill time in patients with stable exertional angina.
Synapse has enriched 10 related papers. Consider them for comparative context: